Literature DB >> 17540735

Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A.

Jesse M Damsker1, Michael I Bukrinsky, Stephanie L Constant.   

Abstract

The recruitment and trafficking of leukocytes are essential aspects of the inflammatory process. Although chemokines are thought to be the main regulators of cell trafficking, extracellular cyclophilins have been shown recently to have potent chemoattracting properties for human leukocytes. Cyclophilins are secreted by a variety of cell types and are detected at high levels in tissues with ongoing inflammation. CD147 has been identified as the main signaling receptor for cyclophilin A (CypA) on human leukocytes. It is interesting that the expression of CD147 is elevated on leukocytes from inflamed tissue, suggesting a correlation among the presence of extracellular cyclophilins, CD147 expression, and inflammatory responses. Thus, cyclophilin-CD147 interactions may contribute directly to the recruitment of leukocytes into inflamed tissues. In the current studies, we show that activated human T lymphocytes express elevated levels of CD147, compared with resting T cells and that these activated T cells migrate more readily to CypA than resting cells. Furthermore, we show that unlike resting CD4+ T cells, the cyclophilin-mediated migration of activated T cells does not require interaction with heparan sulfate receptors but instead, is dependent on CD147 interaction alone. Such findings suggest that cyclophilin-CD147 interactions will be most potent when leukocytes are in an activated state, for example, during inflammatory responses. Thus, targeting cyclophilin-CD147 interactions may provide a novel approach for alleviating tissue inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540735      PMCID: PMC2846690          DOI: 10.1189/jlb.0506317

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  23 in total

1.  Leukocyte chemotactic activity of cyclophilin.

Authors:  Q Xu; M C Leiva; S A Fischkoff; R E Handschumacher; C R Lyttle
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

Review 2.  The role of T-lymphocytes in rheumatoid arthritis.

Authors:  M Salmon; J S Gaston
Journal:  Br Med Bull       Date:  1995-04       Impact factor: 4.291

3.  Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule.

Authors:  W Kasinrerk; E Fiebiger; I Stefanová; T Baumruker; W Knapp; H Stockinger
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

4.  Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages.

Authors:  B Sherry; N Yarlett; A Strupp; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

5.  Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix.

Authors:  Fabrice Allain; Christophe Vanpouille; Mathieu Carpentier; Marie-Christine Slomianny; Sandrine Durieux; Geneviève Spik
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  Active site residues of cyclophilin A are crucial for its signaling activity via CD147.

Authors:  Vyacheslav Yurchenko; Gabriele Zybarth; Matthew O'Connor; Wei Wei Dai; Giovanni Franchin; Tang Hao; Huiming Guo; Hsiu-Cheng Hung; Bryan Toole; Philippe Gallay; Barbara Sherry; Michael Bukrinsky
Journal:  J Biol Chem       Date:  2002-04-09       Impact factor: 5.157

7.  IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis.

Authors:  Nir Grabie; Michael W Delfs; Jason R Westrich; Victoria A Love; George Stavrakis; Ferhaan Ahmad; Christine E Seidman; Jonathan G Seidman; Andrew H Lichtman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Octasaccharide is the minimal length unit required for efficient binding of cyclophilin B to heparin and cell surface heparan sulphate.

Authors:  Christophe Vanpouille; Agnès Denys; Mathieu Carpentier; Rachel Pakula; Joël Mazurier; Fabrice Allain
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

9.  High binding capacity of cyclophilin B to chondrocyte heparan sulfate proteoglycans and its release from the cell surface by matrix metalloproteinases: possible role as a proinflammatory mediator in arthritis.

Authors:  Frédéric De Ceuninck; Fabrice Allain; Audrey Caliez; Geneviève Spik; Paul M Vanhoutte
Journal:  Arthritis Rheum       Date:  2003-08

10.  Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis.

Authors:  A Billich; G Winkler; H Aschauer; A Rot; P Peichl
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

View more
  46 in total

1.  Blocking cyclophilins in the chronic phase of asthma reduces the persistence of leukocytes and disease reactivation.

Authors:  Erik J Stemmy; Molly A Balsley; Rosalyn A Jurjus; Jesse M Damsker; Michael I Bukrinsky; Stephanie L Constant
Journal:  Am J Respir Cell Mol Biol       Date:  2011-04-14       Impact factor: 6.914

Review 2.  Cyclophilin D in mitochondrial pathophysiology.

Authors:  Valentina Giorgio; Maria Eugenia Soriano; Emy Basso; Elena Bisetto; Giovanna Lippe; Michael A Forte; Paolo Bernardi
Journal:  Biochim Biophys Acta       Date:  2009-12-21

3.  CD147-mediated chemotaxis of CD4+CD161+ T cells may contribute to local inflammation in rheumatoid arthritis.

Authors:  Minghua Lv; Jinlin Miao; Peng Zhao; Xing Luo; Qing Han; Zhenbiao Wu; Kui Zhang; Ping Zhu
Journal:  Clin Rheumatol       Date:  2017-09-25       Impact factor: 2.980

4.  Expression of REGγ in atherosclerotic plaques and promotes endothelial cells apoptosis via the cyclophilin A pathway indicates functional implications in atherogenesis.

Authors:  Yifan Xie; Xiaotao Li; Junbo Ge
Journal:  Cell Cycle       Date:  2019-07-07       Impact factor: 4.534

Review 5.  The mitochondrial permeability transition from yeast to mammals.

Authors:  Luca Azzolin; Sophia von Stockum; Emy Basso; Valeria Petronilli; Michael A Forte; Paolo Bernardi
Journal:  FEBS Lett       Date:  2010-04-14       Impact factor: 4.124

6.  The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/- myopathic mice.

Authors:  T Tiepolo; A Angelin; E Palma; P Sabatelli; L Merlini; L Nicolosi; F Finetti; P Braghetta; G Vuagniaux; J-M Dumont; C T Baldari; P Bonaldo; P Bernardi
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

Review 7.  Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.

Authors:  V Yurchenko; S Constant; E Eisenmesser; M Bukrinsky
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

8.  CD147 stimulates HIV-1 infection in a signal-independent fashion.

Authors:  Tatiana Pushkarsky; Vyacheslav Yurchenko; Alicia Laborico; Michael Bukrinsky
Journal:  Biochem Biophys Res Commun       Date:  2007-09-14       Impact factor: 3.575

9.  Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation.

Authors:  Kimio Satoh; Tetsuya Matoba; Jun Suzuki; Michael R O'Dell; Patrizia Nigro; Zhaoqiang Cui; Amy Mohan; Shi Pan; Lingli Li; Zheng-Gen Jin; Chen Yan; Jun-ichi Abe; Bradford C Berk
Journal:  Circulation       Date:  2008-06-09       Impact factor: 29.690

10.  The Stimulation of CD147 Induces MMP-9 Expression through ERK and NF-kappaB in Macrophages: Implication for Atherosclerosis.

Authors:  Ju-Young Kim; Won-Jung Kim; Ho Kim; Kyoungho Suk; Won-Ha Lee
Journal:  Immune Netw       Date:  2009-06-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.